Transarterial Embolization Therapies in Hepatocellular Carcinoma: Principles of Management

Liver Cancers ◽  
2018 ◽  
pp. 123-138
Author(s):  
Tim Cross ◽  
Jonathan C. Evans
Author(s):  
William E. L. Ormiston ◽  
Hooman Yarmohammadi ◽  
Stephanie Lobaugh ◽  
Juliana Schilsky ◽  
Seth S. Katz ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (6) ◽  
pp. e0232371 ◽  
Author(s):  
Ezio Lanza ◽  
Chiara Masetti ◽  
Gaia Messana ◽  
Riccardo Muglia ◽  
Nicola Pugliese ◽  
...  

2013 ◽  
Vol 33 (6) ◽  
pp. 944-949 ◽  
Author(s):  
Emmanuel Tsochatzis ◽  
Matteo Garcovich ◽  
Laura Marelli ◽  
Vassilis Papastergiou ◽  
Evangelia Fatourou ◽  
...  

HPB ◽  
2018 ◽  
Vol 20 ◽  
pp. S80
Author(s):  
M.L. Babicky ◽  
R.K. Do ◽  
W.R. Jarnagin ◽  
P.J. Allen ◽  
R.P. DeMatteo ◽  
...  

2009 ◽  
Vol 16 (4) ◽  
pp. 508-512 ◽  
Author(s):  
Wing-Hong Li ◽  
Edmond Cheung-Yan Cheuk ◽  
Philip Chong-Hei Kowk ◽  
Moon-Tong Cheung

2017 ◽  
Vol 11 (1) ◽  
pp. 155-161
Author(s):  
Severin Gloor ◽  
Kai Oliver Jensen ◽  
Stefan Breitenstein ◽  
Christoph A. Binkert ◽  
Eliane Angst ◽  
...  

Spontaneous ruptures of hepatocellular carcinoma (HCC) are rare. Nevertheless they may lead to difficult decisions in the emergency situation. The acute therapies include conservative treatment, transarterial embolization and surgery. Curative treatment of HCC can be achieved by liver resection solely. The decision-making depends on prognostic patient’s factors, such as hepatic viral infection status, Child-Pugh grade, liver cirrhosis and number of tumors. In this case transarterial embolization was preferable as a bridging therapy prior to further diagnostics and therapy, to lower the perioperative morbidity and mortality. The therapy of these cases needs an interdisciplinary approach to choose the best possible procedure in each case.


Sign in / Sign up

Export Citation Format

Share Document